Hamamatsu University School of Medicine · Department of Second Internal Medicine

Research keywords肺がん・ドライバー遺伝子変異・転座陰性の非小細胞肺癌患者における包括的がんゲノムプロファイリングの有用性を評価する前向き観察研究・非小細胞肺癌・ドライバー遺伝子変異・免疫チェックポイント阻害薬・間質性肺炎・包括的ゲノムプロファイリング・前向き観察研究

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Longitudinal Assessment of Real-World Treatments and Outcomes in Patients with Rheumatoid Arthritis-Associated Interstitial Lung Disease: A Multicenter, Prospective, Observational Study2024 · European Journal of Respiratory Medicine （2024年） [査読] 有
• Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapy.2024 · Respiratory research [巻]25 [号]1 [頁]25 -25 （2024年） [査読] 有
• Characterization of BRAFT599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling.2024 · JCO precision oncology [巻]8 [頁]e2300538 （2024年） [査読] 有
• Six-week oral prednisolone therapy for immune-related pneumonitis: a single-arm phase II study.2023 · Journal for immunotherapy of cancer [巻]11 [号]7 （2023年） [査読] 有

• 細胞形質分化プログラムの破綻を機序とする小細胞肺がんの新規治療戦略の確立
• 小細胞肺がんの運命制御転写因子の相互排他性に注目した新規治療標的の探索

• Official profile